2.34
0.01 (0.43%)
| 前收盘价格 | 2.33 |
| 收盘价格 | 2.36 |
| 成交量 | 108,058 |
| 平均成交量 (3个月) | 145,968 |
| 市值 | 102,062,840 |
| 价格/销量 (P/S) | 0.930 |
| 股市价格/股市净资产 (P/B) | 1.40 |
| 52周波幅 | |
| 利润日期 | 5 Mar 2025 - 10 Mar 2025 |
| 营业毛利率 | -14.57% |
| 营业利益率 (TTM) | -7.72% |
| 稀释每股收益 (EPS TTM) | -0.330 |
| 季度收入增长率 (YOY) | -13.40% |
| 总债务/股东权益 (D/E MRQ) | 70.29% |
| 流动比率 (MRQ) | 2.06 |
| 营业现金流 (OCF TTM) | 4.02 M |
| 杠杆自由现金流 (LFCF TTM) | 6.06 M |
| 资产报酬率 (ROA TTM) | -1.98% |
| 股东权益报酬率 (ROE TTM) | -20.40% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (US) | 混合的 | 混合的 |
| Medical Instruments & Supplies (全球的) | 混合的 | 混合的 | |
| 股票 | Harvard Bioscience, Inc. | 混合的 | 混合的 |
AIStockmoo 评分
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | 1.5 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.50 |
|
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Small Value |
| 内部持股比例 | 7.77% |
| 机构持股比例 | 75.99% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合